-+ 0.00%
-+ 0.00%
-+ 0.00%

Phio Pharmaceuticals Joins Renmark Virtual Non-Deal Roadshow

PUBT·10/19/2026 13:54:16
Listen to the news
Phio Pharmaceuticals Joins Renmark Virtual Non-Deal Roadshow
  • Phio Pharmaceuticals will participate in Renmark Financial Communications’ virtual non-deal roadshow on October 20, 2026, at noon EDT.
  • CEO Robert Bitterman will present the INTASYL siRNA platform, including lead candidate PH-762 for cutaneous carcinomas, followed by live Q&A.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610190953NEWSFILECNPR____20261019_319697_1) on October 19, 2026, and is solely responsible for the information contained therein.